A bone-protective role for IL-17 receptor signaling in ovariectomy-induced bone loss
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Post-menopausal osteoporosis is considered to be an inflammatory process, in which numerous pro-inflammatory and T-cell-derived cytokines play a bone-destructive role. IL-17A is the signature cytokine of the pro-inflammatory Th17 population and plays dichotomous roles in diseases that affect bone turnover. Although IL-17A promotes bone loss in rheumatoid arthritis, it is protective against pathogen-induced bone destruction in a periodontal disease model. We used a model of ovariectomy-induced osteoporosis (OVX) in IL-17 receptor (IL-17RA)(-/-) mice to evaluate the role of the IL-17A in bone loss caused by estrogen deficiency. Unexpectedly, IL-17RA(-/-) mice were consistently and markedly more susceptible to OVX-induced bone loss than controls. There were no changes in prototypical Th1, Th2 or Th17 cytokines in serum that could account for increased bone loss. However, IL-17RA(-/-) mice exhibited constitutively elevated leptin, which further increased following OVX. Consistently, IL-17A and IL-17F treatment of 3T3-L1 pre-adipocytes inhibited adipogenesis, leading to reduced production of leptin. In addition to its role in regulating metabolism and satiety, leptin can regulate bone turnover. Accordingly, these data show that IL-17A negatively regulates adipogenesis and subsequent leptin expression, which correlates with increased bone destruction during OVX.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mice deficient in IL-17 and fed regular chow gain increased fat mass with age, corresponding to a role for IL-17 in regulating glucose homeostasis and inhibiting adipogenesis”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Goswami et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 1×
“IL-17A and the related cytokine IL-17F are produced by a newly-discovered subset of T helper lymphocytes, termed Th17 cells [2].”
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568 · cited 2×
“Estrogen deficiency also increases the RANKL:OPG ratio through increases in pro-inflammatory effectors, including IL-1b, IL-6, IL-11, TNF-a, M-CSF and PGE2 [33–35].”
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Riggs, B. L., Khosla, S., & Melton, L. J. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.3.0465 · Cited by 1,846 · cited 2×
“Estrogen deficiency also increases the RANKL:OPG ratio through increases in pro-inflammatory effectors, including IL-1b, IL-6, IL-11, TNF-a, M-CSF and PGE2 [33–35].”
IL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842 · cited 2×
“TGFβ controls Th17 differentiation, together with IL-6 and IL-1 (reviewed in [3]).”
Sato, K., Suematsu, A., Okamoto, K., Yamaguchi, A., Morishita, Y., Kadono, Y., Tanaka, S., Kodama, T., Akira, S., Iwakura, Y., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061775 · Cited by 1,554 · cited 1×
“In addition, Th17 cells express high levels of RANKL, providing a direct mechanism by which they may drive mediate bone destruction [5].”
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526 · cited 1×
“IL-17A induces production of TNF-α and IL-1β in macrophages [6], and synergizes with IL-1β and TNF-α in many cell backgrounds to increase the synthesis of pro-inflammatory effectors such as IL-6, IL-8 and matrix mellaproteinases [7,8].”
Minireview: The OPG/RANKL/RANK System
Khosla, S. (2001) · Endocrinology · doi:10.1210/endo.142.12.8536 · Cited by 1,515 · cited 1×
“RANKL is inhibited by a soluble decoy receptor OPG (osteoprotegerin), which binds to RANK and prevents osteoclastogenesis [31,32].”
BackgroundIncreased Osteoclast Development After Estrogen Loss: Mediation by Interleukin-6
Jilka, R. L., Hangoc, G., Girasole, G., Passeri, G., Williams, D. C., Abrams, J. S., Boyce, B., Broxmeyer, H., & Manolagas, S. C. (1992) · Science · doi:10.1126/science.1621100 · Cited by 1,442
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/er.21.2.115 · Cited by 1,318
The Osteoblast: A Sophisticated Fibroblast under Central Surveillance
Ducy, P., Schinke, T., & Karsenty, G. (2000) · Science · doi:10.1126/science.289.5484.1501 · Cited by 1,120 · cited 1×
“Leptin has been shown to cause bone loss through a central pathway in the hypothalamus [27].”
Estrogen deficiency and bone loss: an inflammatory tale
Weitzmann, M. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28550 · Cited by 990 · cited 2×
“We assessed multiple cytokines based on their known roles in osteoporosis [11,18,24] or in Th1, Th2 or Th17 cells [16] (see also Discussion).”
Jovanović, D., Battista, J. A. D., Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Martel‐Pelletier, J. (1998) · PubMed · Cited by 973
Jovanovic, D. V., Di Battista, J. A., Martel-Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Pelletier, J.-P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3513 · Cited by 867 · cited 1×
“IL-17A induces production of TNF-α and IL-1β in macrophages [6], and synergizes with IL-1β and TNF-α in many cell backgrounds to increase the synthesis of pro-inflammatory effectors such as IL-6, IL-8 and matrix mellaproteinases [7,8].”
RANK-L and RANK: T Cells, Bone Loss, and Mammalian Evolution
Theill, L. E., Boyle, W. J., & Penninger, J. M. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.100301.064753 · Cited by 819 · cited 1×
“RANKL is inhibited by a soluble decoy receptor OPG (osteoprotegerin), which binds to RANK and prevents osteoclastogenesis [31,32].”
IL-1 mediates TNF-induced osteoclastogenesis
Wei, S., Kitaura, H., Zhou, P., Ross, F. P., & Teitelbaum, S. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523394 · Cited by 795 · cited 1×
“IL-1β, IL-6 and TNF-α are all associated with increased osteoclastogenesis following OVX [9-12].”
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.
Poli, V., Balena, R., Fattori, E., Markatos, A., Yamamoto, M., Tanaka, H., Ciliberto, G., Rodan, G. A., & Costantini, F. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06368.x · Cited by 749 · cited 2×
“IL-1β, IL-6 and TNF-α are all associated with increased osteoclastogenesis following OVX [9-12].”
Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis
Pacifici, R. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110802 · Cited by 741 · cited 2×
“Estrogen deficiency also increases the RANKL:OPG ratio through increases in pro-inflammatory effectors, including IL-1b, IL-6, IL-11, TNF-a, M-CSF and PGE2 [33–35].”
Thomas, T., Gori, F., Khosla, S., Jensen, M. D., Burguera, B., & Riggs, B. L. (1999) · Endocrinology · doi:10.1210/endo.140.4.6637 · Cited by 726 · cited 1×
“Conversely, leptin is bone protective through a peripheral pathway [28,29].”
BackgroundEstrogen deficiency induces bone loss by enhancing T-cell production of TNF-α
Cenci, S., Weitzmann, M. N., Roggia, C., Namba, N., Novack, D., Woodring, J., & Pacifici, R. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11066 · Cited by 705 · cited 2×
“Osteoporosis is a pro-inflammatory state with increased inflammatory cytokines and activated T-cells [19].”
Genetic variability in adult bone density among inbred strains of mice
Beamer, W. G., Donahue, L. R., Rosen, C. J., & Baylink, D. J. (1996) · Bone · doi:10.1016/8756-3282(96)00047-6 · Cited by 630 · cited 1×
“First, we measured the baseline bone mineral density (BMD) in wild type (WT) and IL-17RAKO mice using a PIXImusTM DXA (dual X-ray absorptimetry) densitometer at 16 weeks, as mice acquire peak bone density by this age [20,21].”
Roggia, C., Gao, Y., Cenci, S., Weitzmann, M. N., Toraldo, G., Isaia, G., & Pacifici, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251534698 · Cited by 513 · cited 2×
“There are numerous reports evaluating the role of TNFα in OVX-induced bone loss [13,39-41].”
BackgroundIFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation
Gao, Y., Grassi, F., Ryan, M. R., Terauchi, M., Page, K., Yang, X., Weitzmann, M. N., & Pacifici, R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30074 · Cited by 455 · cited 1×
“This process leads to T cell activation and proliferation, with a consequent upregulation of osteoclastogenic cytokines including RANKL and TNFα [38].”
BackgroundYu, J. J., Ruddy, M. J., Wong, G. C., Sfintescu, C., Baker, P. J., Smith, J. B., Evans, R. T., & Gaffen, S. L. (2007) · Blood · doi:10.1182/blood-2005-09-010116 · Cited by 372 · cited 1×
“gingivalis-induced periodontal bone loss, the IL-17 receptor (IL-17RA) plays a bone-protective function by enhancing neutrophilic responses, which limit bacterial colonization [14-16].”
BackgroundRuddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308809200 · Cited by 364 · cited 3×
“IL-17A has been shown to increase RANKL expression and other inflammatory effectors in OBs, further stimulating bone turnover [8,36].”
BackgroundSelf-citationLubberts, E., van den Bersselaar, L., Oppers-Walgreen, B., Schwarzenberger, P., Coenen-de Roo, C. J. J., Kolls, J. K., Joosten, L. A. B., & van den Berg, W. B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2655 · Cited by 348 · cited 1×
“This occurs in part by upregulating the relative ratio of RANKL (receptor activator of NF-κB ligand) to osteoprotogerin (OPG), which promotes osteoclastogenesis [4].”
Gaffen, S. L., & Hajishengallis, G. (2008) · Journal of Dental Research · doi:10.1177/154405910808700908 · Cited by 334 · cited 2×
“gingivalis-induced periodontal bone loss, the IL-17 receptor (IL-17RA) plays a bone-protective function by enhancing neutrophilic responses, which limit bacterial colonization [14-16].”
Self-citationRickel, E. A., Siegel, L. A., Yoon, B.-R. P., Rottman, J. B., Kugler, D. G., Swart, D. A., Anders, P. M., Tocker, J. E., Comeau, M. R., & Budelsky, A. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4299 · Cited by 321 · cited 1×
“For example, it was recently shown that IL-17RA is an essential receptor for IL-17E/IL-25 signaling [47].”
Cenci, S., Toraldo, G., Weitzmann, M. N., Roggia, C., Gao, Y., Qian, W. P., Sierra, O., & Pacifici, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1533207100 · Cited by 309
IL-17/Th17 targeting: On the road to prevent chronic destructive arthritis?
Lubberts, E. (2008) · Cytokine · doi:10.1016/j.cyto.2007.09.014 · Cited by 289 · cited 2×
“Blocking IL-17A or IL-23 in collagen-induced arthritis (CIA) reduces disease, and IL-17A-deficient mice are resistant to CIA and spontaneous arthritis in IL-1Ra-deficient mice (reviewed in [1]).”
BackgroundIncreased activity of interleukin-23/interleukin-17 proinflammatory axis in obese women
Sumarac-Dumanovic, M., Stevanovic, D., Ljubic, A., Jorga, J., Simic, M., Stamenkovic-Pejkovic, D., Starcevic, V, Trajkovic, V, & Micic, D. (2009) · International Journal of Obesity · doi:10.1038/ijo.2008.216 · Cited by 286 · cited 1×
“Counter to this, in a small study of obese humans, IL-17A and IL-23 have been linked to obesity, independent of leptin levels [46].”
Kimble, R. B., Matayoshi, A. B., Vannice, J. L., Kung, V. T., Williams, C., & Pacifici, R. (1995) · Endocrinology · doi:10.1210/endo.136.7.7789332 · Cited by 273 · cited 2×
“There are numerous reports evaluating the role of TNFα in OVX-induced bone loss [13,39-41].”
BackgroundHuang, H., Kim, H. J., Chang, E.-J., Lee, Z. H., Hwang, S. J., Kim, H.-M., Lee, Y., & Kim, H.-H. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.74 · Cited by 272 · cited 1×
“Moreover, IL-17 accelerates differentiation of hMSCs into osteoblasts [45].”
Kimble, R. B., Srivastava, S., Ross, F. P., Matayoshi, A., & Pacifici, R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28890 · Cited by 272 · cited 1×
“There are numerous reports evaluating the role of TNFα in OVX-induced bone loss [13,39-41].”
BackgroundShen, F., Ruddy, M. J., Plamondon, P., & Gaffen, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904490 · Cited by 268 · cited 1×
“IL-17A has been shown to increase RANKL expression and other inflammatory effectors in OBs, further stimulating bone turnover [8,36].”
BackgroundSelf-citationOvariectomy-Induced Bone Loss Varies Among Inbred Strains of Mice
Bouxsein, M. L., Myers, K. S., Shultz, K. L., Donahue, L. R., Rosen, C. J., & Beamer, W. G. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050307 · Cited by 251 · cited 1×
“First, we measured the baseline bone mineral density (BMD) in wild type (WT) and IL-17RAKO mice using a PIXImusTM DXA (dual X-ray absorptimetry) densitometer at 16 weeks, as mice acquire peak bone density by this age [20,21].”
The Functional Block of TNF but Not of IL-6 Prevents Bone Loss in Ovariectomized Mice
Kimble, R. B., Bain, S., & Pacifici, R. (1997) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1997.12.6.935 · Cited by 241 · cited 1×
“There are numerous reports evaluating the role of TNFα in OVX-induced bone loss [13,39-41].”
Ruddy, M. J., Shen, F., Smith, J. B., Sharma, A., & Gaffen, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0204065 · Cited by 206 · cited 1×
“In addition, since IL-17A and IL-17F are known to exhibit potent synergy with TNFα [30], we also evaluated the effects of these cytokines in the presence of low levels (2 ng/ml) of TNFα.”
Leptin in humans: lessons from translational research
Blüher, S., & Mantzoros, C. S. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26788e · Cited by 203 · cited 2×
“Leptin plays roles in both bone turnover and weight control [25], and here we show that IL-17 signaling inhibits both adipogenesis and leptin expression.”
The role of T lymphocytes in bone metabolism
Weitzmann, M. N., & Pacifici, R. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00324.x · Cited by 192 · cited 2×
“Cytokines produced or regulated by T cells can enhance OC formation during inflammation and estrogen deficiency by increasing the RANKL:OPG ratio [24].”
Estrogen prevents bone loss through transforming growth factor β signaling in T cells
Gao, Y., Qian, W.-P., Dark, K., Toraldo, G., Lin, A. S. P., Guldberg, R. E., Flavell, R. A., Weitzmann, M. N., & Pacifici, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404888101 · Cited by 177 · cited 2×
“Estrogen prevents bone loss through TGFβ signaling in T cells [22].”
Shin, J. H., Shin, D. W., & Noh, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.008 · Cited by 144 · cited 1×
“Consistent with this, a new report shows that IL-17A inhibits adipocyte differentiation and adiponectin expression in a human mesenchymal stem cell (hMSC) system [44].”
Wu, J., Wang, X., Chiba, H., Higuchi, M., Nakatani, T., Ezaki, O., Cui, H., Yamada, K., & Ishimi, Y. (2004) · Metabolism · doi:10.1016/j.metabol.2004.01.019 · Cited by 118 · cited 1×
“Following OVX, both WT and IL-17RAKO mice gained weight, as described previously [23].”
MethodNagata, T., Mckinley, L., Peschon, J. J., Alcorn, J. F., Aujla, S. J., & Kolls, J. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.11.7473 · Cited by 99 · cited 1×
“Although IL-17A is often elevated in IL-17RAKO mice [43], we did not find an increase in this cohort, nor did levels change substantially during OVX.”
Quinn, J. M. W., Sims, N. A., Saleh, H., Mirosa, D., Thompson, K., Bouralexis, S., Walker, E. C., Martin, T. J., & Gillespie, M. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5720 · Cited by 94 · cited 3×
“There is also evidence that IL-23 inhibits osteoclastogenesis and is required for maintenance of bone mass in mice [17], indicating a bone-protective role for IL-23 that is independent of infection.”
Impact of cytokines and T lymphocytes upon osteoclast differentiation and function
Gillespie, M. T. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2141 · Cited by 94 · cited 1×
“Conversely, while T cells are a source of pro-osteolytic stimuli, they can also secrete factors that inhibit osteoclast formation, including IFN-γ, GM-CSF, IL-3, OPG, IL-4, IL-10, IL-13, and osteoclast inhibitory lectin (OCIL) [17,37].”
IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling
Rong, Z., Wang, A., Li, Z., Ren, Y., Cheng, L., Li, Y., Wang, Y., Ren, F., Zhang, X., Hu, J., et al. (2008) · Cell Research · doi:10.1038/cr.2008.320 · Cited by 86
Yu, J. J., Ruddy, M. J., Conti, H. R., Boonanantanasarn, K., & Gaffen, S. L. (2008) · Infection and Immunity · doi:10.1128/iai.01209-07 · Cited by 85 · cited 2×
“Interestingly, the effects of IL-17A are more profound in female mice, suggesting a gender-biased activity of this cytokine [14].”
エストロゲンの欠乏は,インターフェロン‐γ誘導性クラスIIトランスアクチベーターを介するT細胞増殖と寿命の上昇により骨消失を誘導する
Cenci, S., Toraldo, G., Weitzmann, M. N., Roggia, C., Yongli, G., Qian, W. P., Sierra, O., & Pacifici, R. (2003) · Cited by 73
Leptin as an endocrine signal in bone
Lee, N. J., Wong, I. P. L., Baldock, P. A. J., & Herzog, H. (2008) · Current Osteoporosis Reports · doi:10.1007/s11914-008-0011-y · Cited by 22 · cited 4×
“Leptin also exerts effects peripherally through direct action on osteoblasts, resulting in increased bone mass [28].”
InfluentialFrost, A., Jonsson, K. B., Brändström, H., Ohlsson, C., Ljunghall, S., & Ljunggren, Ö. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5127 · Cited by 17 · cited 1×
“IL-13 has been shown to inhibit proliferation and stimulate IL-6 formation in human OBs [42].”
The hypothalamic control of bone mass, implication for the treatment of osteoporosis
Karsenty, G., & Ducy, P. F. (2006) · Annales d Endocrinologie · doi:10.1016/s0003-4266(06)72566-5 · Cited by 17 · cited 1×
“Leptin was first discovered for its role in controlling satiety and body weight, but has since been implicated in bone metabolism [25,26].”
Frost, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.9.3285 · Cited by 14
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Mice deficient in IL-17 and fed regular chow gain increased fat mass with age, corresponding to a role for IL-17 in regulating glucose homeostasis and inhibiting adipogenesis (Ahmed and Gaffen, 2013; Goswami et al., 2009; Zuniga et al., 2010).”
BackgroundSelf-citationOsteoimmunology: The conceptual framework unifying the immune and skeletal systems
Okamoto, K., Nakashima, T., Shinohara, M., Negishi-Koga, T., Komatsu, N., Terashima, A., Sawa, S., Nitta, T., & Takayanagi, H. (2017) · Physiological Reviews · doi:10.1152/physrev.00036.2016 · Cited by 534
“However, inconsistent results have been reported on the role of IL-17 receptor IL-17RA in the pathogenesis of estrogen deficiency-induced osteoporosis; IL-17RA-deficient mice reportedly have a lower bone mineral density than wildtype mice after Ovx (141).”
ResultIL-17 regulates adipogenesis, glucose homeostasis, and obesity
Zúñiga, L. A., Shen, W.-J., Joyce-Shaikh, B., Pyatnova, E. A., Richards, A. G., Thom, C., Andrade, S. M., Cua, D. J., Kraemer, F. B., & Butcher, E. C. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001269 · Cited by 394
Vitamin D and Bone Health; Potential Mechanisms
Laird, E., Ward, M., McSorley, E., Strain, J. J., & Wallace, J. (2010) · Nutrients · doi:10.3390/nu2070693 · Cited by 358
Tyagi, A. M., Srivastava, K., Mansoori, M. N., Trivedi, R., Chattopadhyay, N., & Singh, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044552 · Cited by 326
“While the studies by Goswami et al, 2009 [26] have shown that Ovx IL-17 receptor knockout mice were more susceptible to bone loss than controls thus suggesting a bone protective role for IL-17 receptor signalling, contrasting observations by our group [27] and DeSelm et al [28] suggested that IL-17…”
Result
Metadata
- Authors
- Goswami, J., Hernández‐Santos, N., Zuniga, L. A., & Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- Stanford University (US)
- Corresponding author
- Gaffen, Sarah L.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2009-10
- Volume
- 39
- Issue
- 10
- Pages
- 2831-2839
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- PMC
- PMC2811493
- OpenAlex
- W2122724238
- Cited by
- 87
- References
- 51
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 2 · 2023: 7 · 2022: 3 · 2021: 7 · 2020: 3 · 2019: 4 · 2018: 7 · 2017: 3 · 2016: 7 · 2015: 3 · 2014: 3 · 2013: 9 · 2012: 11
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Amgen
- State University of New York
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (F31-AI073198-02, F31AI073198)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR054389, R01AR054389)
- National Institute of Dental and Craniofacial Research (DE019424, R01DE019424)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- IL-17A, IL-17 receptor, ovariectomy-induced bone loss, postmenopausal osteoporosis, estrogen deficiency, leptin, adipogenesis, 3T3-L1 preadipocytes, Th17 cells, bone turnover, IL-17F
- MeSH terms
- Animals, Estrogens, Female, Mice, Inbred C57BL, Models, Biological, Osteoporosis, Ovariectomy, Spine, Tumor Necrosis Factor-alpha, Signal Transduction, Weight Gain, Bone Density, Down-Regulation, Cytokines, Adipocytes, Mice, Knockout, Interleukin-17, Leptin, 3T3-L1 Cells, Adipogenesis, Mice, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.